{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:33:05Z","timestamp":1775521985673,"version":"3.50.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.celrep.2022.110303","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T10:43:59Z","timestamp":1643712239000},"page":"110303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7676-3707","authenticated-orcid":false,"given":"Mehmet","family":"Sahin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4387-7294","authenticated-orcid":false,"given":"Melissa M.","family":"Remy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedict","family":"Fallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Sommerstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Florova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-9650","authenticated-orcid":false,"given":"Anna","family":"Langner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Klausz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Straub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0335-2733","authenticated-orcid":false,"given":"Mario","family":"Kreutzfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia T.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Malinge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Magistrelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozo","family":"Izui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanspeter","family":"Pircher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Sjef","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doron","family":"Merkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Peipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1594-3189","authenticated-orcid":false,"given":"Daniel D.","family":"Pinschewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2022.110303_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41577-020-0365-7","article-title":"Passive antibody therapy in COVID-19","volume":"20","author":"Abraham","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06741-w","article-title":"Non-neutralizing antibodies elicited by recombinant Lassa\u2013Rabies vaccine are critical for protection against Lassa fever","volume":"9","author":"Abreu-Mota","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.110303_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"Anthony","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110303_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","article-title":"Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24-or 96-well plates","volume":"33","author":"Battegay","year":"1991","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.celrep.2022.110303_bib5","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.4049\/jimmunol.181.9.6664","article-title":"Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions","volume":"181","author":"Baudino","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib6","doi-asserted-by":"crossref","first-page":"21641","DOI":"10.1073\/pnas.1011998107","article-title":"Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression","volume":"107","author":"Bergthaler","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.celrep.2022.110303_bib7","doi-asserted-by":"crossref","first-page":"e1000080","DOI":"10.1371\/journal.pbio.1000080","article-title":"Impaired antibody response causes persistence of prototypic T cell\u2013contained virus","volume":"7","author":"Bergthaler","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.celrep.2022.110303_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1099\/vir.0.82428-0","article-title":"Contributions of the lymphocytic choriomeningitis virus glycoprotein and polymerase to strain-specific differences in murine liver pathogenicity","volume":"88","author":"Bergthaler","year":"2007","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02970145","article-title":"Viral mimicry of the complement system","volume":"28","author":"Bernet","year":"2003","journal-title":"J.\u00a0Biosci."},{"key":"10.1016\/j.celrep.2022.110303_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0598-56","article-title":"Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies","volume":"19","author":"Botto","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2022.110303_bib11","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.20151267","article-title":"The role of Fc\u2013Fc\u03b3R interactions in IgG-mediated microbial neutralization","volume":"212","author":"Bournazos","year":"2015","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.110303_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.immuni.2017.07.009","article-title":"Fc\u03b3 receptor function and the design of vaccination strategies","volume":"47","author":"Bournazos","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.110303_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0042-6822(83)90135-6","article-title":"Lymphocytic choriomeningitis virus. VI. Isolation a glycoprotein mediating neutralization","volume":"130","author":"Bruns","year":"1983","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2022.110303_bib14","doi-asserted-by":"crossref","first-page":"e106228","DOI":"10.15252\/embj.2020106228","article-title":"Viral nucleoprotein antibodies activate TRIM21 and induce T\u00a0cell immunity","volume":"40","author":"Caddy","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2022.110303_bib15","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1126\/science.1083182","article-title":"Antibody domain exchange is an immunological solution to carbohydrate cluster recognition","volume":"300","author":"Calarese","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110303_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.110303_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.aap8131","article-title":"Broadly neutralizing antibodies to prevent HIV-1","volume":"358","author":"Cohen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110303_bib18","series-title":"Paper Presented at: Springer Seminars in Immunopathology","article-title":"Complement, viruses, and virus-infected cells","author":"Cooper","year":"1983"},{"key":"10.1016\/j.celrep.2022.110303_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/vim.2000.13.83","article-title":"Neutralizing monoclonal antibody to the E1 glycoprotein epitope of rubella virus mediates virus arrest in VERO cells","volume":"13","author":"Cordoba","year":"2000","journal-title":"Viral Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coviro.2017.03.002","article-title":"Tackling influenza with broadly neutralizing antibodies","volume":"24","author":"Corti","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","article-title":"Broadly neutralizing antiviral antibodies","volume":"31","author":"Corti","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.antiviral.2016.08.012","article-title":"Treatment of Lassa virus infection in outbred Guinea pigs with first-in-class human monoclonal antibodies","volume":"133","author":"Cross","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.celrep.2022.110303_bib23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/19420862.2017.1323159","article-title":"Affinity of human IgG subclasses to mouse Fc gamma receptors","volume":"9","author":"Dekkers","year":"2017","journal-title":"MAbs"},{"key":"10.1016\/j.celrep.2022.110303_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/rmv.419","article-title":"Valency of antibody binding to virions and its determination by surface plasmon resonance","volume":"14","author":"Dimmock","year":"2004","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/jvi.13.2.269-275.1974","article-title":"Inhibition of virus release by antibodies to surface antigens of influenza viruses","volume":"13","author":"Dowdle","year":"1974","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01314487","article-title":"Inhibition of bovine leukemia virus release by antiviral antibodies","volume":"55","author":"Driscoll","year":"1977","journal-title":"Arch. Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib27","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1099\/vir.0.83041-0","article-title":"Superinfection exclusion in BHK-21 cells persistently infected with Junin virus","volume":"88","author":"Ellenberg","year":"2007","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib28","first-page":"38","article-title":"Prevention strategies for respiratory syncytial virus: passive and active immunization","volume":"135","author":"Englund","year":"1999","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.celrep.2022.110303_bib29","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1128\/JVI.00955-07","article-title":"Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus","volume":"81","author":"Eschli","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib31","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1084\/jem.20090766","article-title":"Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation","volume":"207","author":"Fafi-Kremer","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.110303_bib32","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.celrep.2019.12.023","article-title":"Chronic viral infection promotes efficient germinal center B cell responses","volume":"30","author":"Fallet","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.110303_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jgm.1032","article-title":"A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells","volume":"9","author":"Fischer","year":"2007","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.celrep.2022.110303_bib34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41577-018-0003-9","article-title":"A cold-blooded view of adaptive immunity","volume":"18","author":"Flajnik","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib35","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1073\/pnas.0600652103","article-title":"Recovery of an arenavirus entirely from RNA polymerase I\/II-driven cDNA","volume":"103","author":"Flatz","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.celrep.2022.110303_bib36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nm.2104","article-title":"Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T\u00a0cell immunity","volume":"16","author":"Flatz","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.110303_bib37","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cell.2015.10.050","article-title":"Broadly neutralizing alphavirus antibodies bind an epitope on E2 and inhibit entry and egress","volume":"163","author":"Fox","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.110303_bib38","doi-asserted-by":"crossref","first-page":"e1001098","DOI":"10.1371\/journal.ppat.1001098","article-title":"Steric shielding of surface epitopes and impaired immune recognition induced by the Ebola virus glycoprotein","volume":"6","author":"Francica","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.110303_bib39","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.4049\/jimmunol.1700429","article-title":"A restricted role for Fc\u03b3R in the regulation of adaptive immunity","volume":"200","author":"Fransen","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib40","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1084\/jem.174.6.1425","article-title":"Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression","volume":"174","author":"Fung-Leung","year":"1991","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.110303_bib41","doi-asserted-by":"crossref","first-page":"eaam8686","DOI":"10.1126\/sciimmunol.aam8686","article-title":"Sustained T follicular helper cell response is essential for control of chronic viral infection","volume":"2","author":"Greczmiel","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib42","doi-asserted-by":"crossref","first-page":"19637","DOI":"10.1074\/jbc.M110.117382","article-title":"Enhancing antibody Fc heterodimer formation through electrostatic steering effects: applications to bispecific molecules and monovalent IgG","volume":"285","author":"Gunasekaran","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2022.110303_bib43","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.20051557","article-title":"Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread","volume":"203","author":"Hangartner","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.110303_bib44","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.1208421","article-title":"Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection","volume":"334","author":"Harker","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110303_bib45","doi-asserted-by":"crossref","first-page":"19733","DOI":"10.1073\/pnas.1210659109","article-title":"AAA ATPase p97\/VCP is essential for TRIM21-mediated virus neutralization","volume":"109","author":"Hauler","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.celrep.2022.110303_bib46","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1128\/JVI.72.5.4396-4402.1998","article-title":"Structure of a neutralizing antibody bound monovalently to human rhinovirus 2","volume":"72","author":"Hewat","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib47","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3390\/v1031265","article-title":"Antibody-mediated Fc\u03b3 receptor-based mechanisms of HIV inhibition: recent findings and new vaccination strategies","volume":"1","author":"Holl","year":"2009","journal-title":"Viruses"},{"key":"10.1016\/j.celrep.2022.110303_bib48","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.4049\/jimmunol.172.10.6239","article-title":"Visualizing the viral burden: phenotypic and functional alterations of T\u00a0cells and APCs during persistent infection","volume":"172","author":"Homann","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib49","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cell.2017.06.048","article-title":"Non-neutralizing antibodies alter the course of HIV-1 infection in\u00a0vivo","volume":"170","author":"Horwitz","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.110303_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni911","article-title":"Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections","volume":"4","author":"Hunziker","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib51","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1073\/pnas.0609174104","article-title":"Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function","volume":"104","author":"James","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.celrep.2022.110303_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.chom.2018.07.018","article-title":"Neutralizing antibodies inhibit chikungunya virus budding at the plasma membrane","volume":"24","author":"Jin","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2022.110303_bib53","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.celrep.2015.11.043","article-title":"Neutralizing monoclonal antibodies block chikungunya virus entry and release by targeting an epitope critical to viral pathogenesis","volume":"13","author":"Jin","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.110303_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00136-16","article-title":"Inhibitory antibodies targeting emerging viruses: advancements and mechanisms","author":"Jin","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib55","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1365-3083.2000.00790.x","article-title":"Role of J chain in secretory immunoglobulin formation","volume":"52","author":"Johansen","year":"2000","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib56","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.4049\/jimmunol.1401771","article-title":"Protective efficacy of individual CD8+ T\u00a0cell specificities in chronic viral infection","volume":"194","author":"Johnson","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib57","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1073\/pnas.93.11.5512","article-title":"The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor","volume":"93","author":"Junghans","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.celrep.2022.110303_bib58","doi-asserted-by":"crossref","first-page":"13467","DOI":"10.1128\/JVI.01896-12","article-title":"Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein","volume":"86","author":"Kajihara","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib59","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1002\/eji.1830261202","article-title":"Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection","volume":"26","author":"Kalinke","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1073\/pnas.0307124101","article-title":"The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen","volume":"101","author":"Kang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.celrep.2022.110303_bib61","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/eji.1830241025","article-title":"Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor","volume":"24","author":"Kim","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib62","doi-asserted-by":"crossref","first-page":"157895","DOI":"10.1155\/2014\/157895","article-title":"Neutralization of virus infectivity by antibodies: old problems in new perspectives","volume":"2014","author":"Klasse","year":"2014","journal-title":"Adv. Biol."},{"key":"10.1016\/j.celrep.2022.110303_bib63","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1099\/0022-1317-83-9-2091","article-title":"Occupancy and mechanism in antibody-mediated neutralization of animal viruses","volume":"83","author":"Klasse","year":"2002","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.sbi.2016.10.019","article-title":"Camelid and shark single domain antibodies: structural features and therapeutic potential","volume":"45","author":"K\u00f6nning","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.celrep.2022.110303_bib65","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/JVI.74.4.1961-1972.2000","article-title":"Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus","volume":"74","author":"Kwong","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib66","doi-asserted-by":"crossref","first-page":"19985","DOI":"10.1073\/pnas.1014074107","article-title":"Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)","volume":"107","author":"Mallery","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.celrep.2022.110303_bib67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/COH.0000000000000357","article-title":"Role of nonneutralizing antibodies in vaccines and\/or HIV infected individuals","volume":"12","author":"Mayr","year":"2017","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.celrep.2022.110303_bib68","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3389\/fimmu.2017.01590","article-title":"Non-neutralizing antibodies directed against HIV and their functions","volume":"8","author":"Mayr","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib69","series-title":"Progress in Molecular Biology and Translational Science","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/bs.pmbts.2014.10.006","article-title":"TRIM21-dependent intracellular antibody neutralization of virus infection","author":"McEwan","year":"2015"},{"key":"10.1016\/j.celrep.2022.110303_bib70","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1073\/pnas.0810796106","article-title":"Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice","volume":"106","author":"Montoyo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.celrep.2022.110303_bib71","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.it.2015.04.005","article-title":"Fc\u03b3R dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities","volume":"36","author":"Nimmerjahn","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib72","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory actions of intravenous immunoglobulin","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib73","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.ppat.0030009","article-title":"Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys","volume":"3","author":"Oswald","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.110303_bib74","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1126\/science.aaa2148","article-title":"Vaccine-elicited CD4 T\u00a0cells induce immunopathology after chronic LCMV infection","volume":"347","author":"Penaloza-MacMaster","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110303_bib75","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/intimm\/dxq061","article-title":"Innate and adaptive immune control of genetically engineered live-attenuated arenavirus vaccine prototypes","volume":"22","author":"Pinschewer","year":"2010","journal-title":"Int. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib76","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI200422374","article-title":"Kinetics of protective antibodies are determined by the viral surface antigen","volume":"114","author":"Pinschewer","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.110303_bib77","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib78","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/eji.201343566","article-title":"Non-neutralizing antibodies protect from chronic LCMV infection independently of activating Fc\u03b3R or complement","volume":"43","author":"Richter","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib79","doi-asserted-by":"crossref","first-page":"11544","DOI":"10.1038\/ncomms11544","article-title":"Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits","volume":"7","author":"Robinson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.110303_bib80","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib81","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2172-5-8","article-title":"Diversity and repertoire of IgW and IgM VH families in the newborn nurse shark","volume":"5","author":"Rumfelt","year":"2004","journal-title":"BMC Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib82","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1084\/jem.187.4.649","article-title":"Induction of protective cytotoxic T\u00a0cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization","volume":"187","author":"Seiler","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.110303_bib83","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1128\/JVI.72.3.2253-2258.1998","article-title":"Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice","volume":"72","author":"Seiler","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib84","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000150182","article-title":"Immune inhibition of virus release from human and nonhuman cells by antibody to viral and host cell determinants","volume":"32","author":"Shariff","year":"1991","journal-title":"Intervirology"},{"key":"10.1016\/j.celrep.2022.110303_bib85","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R","volume":"276","author":"Shields","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2022.110303_bib86","doi-asserted-by":"crossref","first-page":"e1005276","DOI":"10.1371\/journal.ppat.1005276","article-title":"Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection","volume":"11","author":"Sommerstein","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.110303_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-020-00162-6","article-title":"Antibody development for preventing the human respiratory syncytial virus pathology","volume":"26","author":"Soto","year":"2020","journal-title":"Mol. Med."},{"key":"10.1016\/j.celrep.2022.110303_bib88","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.20020400","article-title":"Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung","volume":"196","author":"Spiekermann","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.110303_bib89","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/eji.201343565","article-title":"Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcgammaR","volume":"43","author":"Straub","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib90","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1099\/0022-1317-78-8-2041","article-title":"Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation","volume":"78","author":"Vanderplasschen","year":"1997","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib91","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1128\/JVI.00545-10","article-title":"Neutralization efficiency is greatly enhanced by bivalent binding of an antibody to epitopes in the V4 region and the membrane-proximal external region within one trimer of human immunodeficiency virus type 1 glycoproteins","volume":"84","author":"Wang","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.110303_bib92","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.4049\/jimmunol.1200212","article-title":"Evidence of IgY subclass diversification in snakes: evolutionary implications","volume":"189","author":"Wang","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib93","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110303_bib94","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.4049\/jimmunol.0803251","article-title":"Expression of IgM, IgD, and IgY in a reptile, Anolis carolinensis","volume":"183","author":"Wei","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib95","doi-asserted-by":"crossref","first-page":"11490","DOI":"10.1073\/pnas.92.25.11490","article-title":"Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity","volume":"92","author":"Wessels","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.celrep.2022.110303_bib96","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2015.01.009","article-title":"Antibody effector functions mediated by Fc\u03b3-receptors are compromised during persistent viral infection","volume":"42","author":"Wieland","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.110303_bib97","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.cell.2021.04.042","article-title":"Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies","volume":"184","author":"Williams","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.110303_bib98","doi-asserted-by":"crossref","first-page":"14438","DOI":"10.1002\/anie.201909343","article-title":"Harnessing evolution to make medicines (Nobel Lecture)","volume":"58","author":"Winter","year":"2019","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.celrep.2022.110303_bib99","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jmb.2005.04.049","article-title":"Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization","volume":"350","author":"Wu","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.celrep.2022.110303_bib100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2015.01.005","article-title":"Suppression of Fc\u03b3-receptor-mediated antibody effector function during persistent viral infection","volume":"42","author":"Yamada","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.110303_bib101","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.4049\/jimmunol.0804121","article-title":"Gene disruption study reveals a nonredundant role for TRIM21\/Ro52 in NF-\u03baB-dependent cytokine expression in fibroblasts","volume":"182","author":"Yoshimi","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib102","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T\u00a0cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.110303_bib103","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/brv.12325","article-title":"IgY: a key isotype in antibody evolution","volume":"92","author":"Zhang","year":"2017","journal-title":"Biol. Rev."},{"key":"10.1016\/j.celrep.2022.110303_bib104","first-page":"1","article-title":"Lymphocytic choriomeningitis virus and immunology","volume":"263","author":"Zinkernagel","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.celrep.2022.110303_bib105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0042-6822(88)90397-2","article-title":"Lymphocytic choriomeningitis virus. X. Demonstration of nucleoprotein on the surface of infected cells","volume":"162","author":"Zeller","year":"1988","journal-title":"Virology"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:34:40Z","timestamp":1761910480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124722000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2211124722000158"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2022.110303","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2022.110303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"110303"}}